219 related articles for article (PubMed ID: 30384328)
21. Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro.
Nishiyama T; Kobayashi T; Jirintai S; Nagashima S; Primadharsini PP; Nishizawa T; Okamoto H
Antiviral Res; 2019 Oct; 170():104570. PubMed ID: 31362004
[TBL] [Abstract][Full Text] [Related]
22. Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients.
Ollivier-Hourmand I; Lebedel L; Lecouf A; Allaire M; Nguyen TTN; Lier C; Dao T
BMC Infect Dis; 2020 Jul; 20(1):522. PubMed ID: 32677900
[TBL] [Abstract][Full Text] [Related]
23. First Case Genotype 4 Hepatitis E Infection After a Liver Transplant.
Wu CH; Ho CM; Tsai JH; Sun HY; Hu RH; Lee PH
Exp Clin Transplant; 2017 Apr; 15(2):228-230. PubMed ID: 26221721
[TBL] [Abstract][Full Text] [Related]
24. Sofosbuvir monotherapy fails to achieve HEV RNA elimination in patients with chronic hepatitis E - The HepNet SofE pilot study.
Cornberg M; Pischke S; Müller T; Behrendt P; Piecha F; Benckert J; Todt D; Steinmann E; Papkalla A; von Karpowitz M; Koch A; Lohse A; Hardtke S; Manns MP; Wedemeyer H
J Hepatol; 2020 Sep; 73(3):696-699. PubMed ID: 32624195
[No Abstract] [Full Text] [Related]
25. Genotype 4 hepatitis E virus is a cause of chronic hepatitis in renal transplant recipients in Hong Kong.
Sridhar S; Chan JFW; Yap DYH; Teng JLL; Huang C; Yip CCY; Hung IFN; Tang SCW; Lau SKP; Woo PCY; Yuen KY
J Viral Hepat; 2018 Feb; 25(2):209-213. PubMed ID: 28984015
[No Abstract] [Full Text] [Related]
26. Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver.
Sayed IM; Verhoye L; Cocquerel L; Abravanel F; Foquet L; Montpellier C; Debing Y; Farhoudi A; Wychowski C; Dubuisson J; Leroux-Roels G; Neyts J; Izopet J; Michiels T; Meuleman P
Gut; 2017 May; 66(5):920-929. PubMed ID: 27006186
[TBL] [Abstract][Full Text] [Related]
27. Failure to respond to ribavirin despite elevated intra-erythrocyte zinc level in transplant-patients with chronic hepatitis E virus infection.
Marion O; Abravanel F; Izopet J; Kamar N
Transpl Infect Dis; 2019 Apr; 21(2):e13050. PubMed ID: 30663838
[No Abstract] [Full Text] [Related]
28. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
[TBL] [Abstract][Full Text] [Related]
29. Modelling of Hepatitis E virus RNA-dependent RNA polymerase genotype 3 from a chronic patient and
Cancela F; Rendon-Marin S; Quintero-Gil C; Houston DR; Gumbis G; Panzera Y; Pérez R; Arbiza J; Mirazo S
J Biomol Struct Dyn; 2023 Feb; 41(2):705-721. PubMed ID: 34861797
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis E Virus Drug Development.
Kinast V; Burkard TL; Todt D; Steinmann E
Viruses; 2019 May; 11(6):. PubMed ID: 31141919
[TBL] [Abstract][Full Text] [Related]
31. [Chronic Hepatitis E Virus Infection and Treatment in Organ Transplant Recipients].
Chen S; Wei F; Wu T; Xia N
Bing Du Xue Bao; 2015 May; 31(3):293-8. PubMed ID: 26470537
[TBL] [Abstract][Full Text] [Related]
32. Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replication.
Praditya DF; Klöhn M; Brüggemann Y; Brown LE; Porco JA; Zhang W; Kinast V; Kirschning A; Vondran FWR; Todt D; Steinmann E
Antiviral Res; 2022 Aug; 204():105359. PubMed ID: 35728703
[TBL] [Abstract][Full Text] [Related]
33. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
[TBL] [Abstract][Full Text] [Related]
34. Treatment of chronic hepatitis E in a patient with HIV infection.
Dalton HR; Keane FE; Bendall R; Mathew J; Ijaz S
Ann Intern Med; 2011 Oct; 155(7):479-80. PubMed ID: 21969351
[TBL] [Abstract][Full Text] [Related]
35. Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment.
Alric L; Bonnet D; Beynes-Rauzy O; Izopet J; Kamar N
Am J Gastroenterol; 2011 Aug; 106(8):1562-3. PubMed ID: 21811285
[No Abstract] [Full Text] [Related]
36. Long-term hepatitis E viral load kinetics in an immunocompromised patient treated with ribavirin.
Ambrosioni J; Mamin A; Hadengue A; Bernimoulin M; Samii K; Landelle C; Negro F; Kaiser L
Clin Microbiol Infect; 2014 Oct; 20(10):O718-20. PubMed ID: 24476456
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis E virus infection.
Kamar N; Izopet J; Pavio N; Aggarwal R; Labrique A; Wedemeyer H; Dalton HR
Nat Rev Dis Primers; 2017 Nov; 3():17086. PubMed ID: 29154369
[TBL] [Abstract][Full Text] [Related]
38. Persisting hepatitis E virus infection leading to liver cirrhosis despite recovery of the immune system in an HIV-infected patient.
Ingiliz P; Mayr C; Obermeier M; Herbst H; Polywka S; Pischke S
Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):e23-e25. PubMed ID: 27055386
[TBL] [Abstract][Full Text] [Related]
39. Ribavirin for chronic hepatitis E virus infection in transplant recipients.
Kamar N; Izopet J; Tripon S; Bismuth M; Hillaire S; Dumortier J; Radenne S; Coilly A; Garrigue V; D'Alteroche L; Buchler M; Couzi L; Lebray P; Dharancy S; Minello A; Hourmant M; Roque-Afonso AM; Abravanel F; Pol S; Rostaing L; Mallet V
N Engl J Med; 2014 Mar; 370(12):1111-20. PubMed ID: 24645943
[TBL] [Abstract][Full Text] [Related]
40. Treatment of Hepatitis E.
Hui W; Wei L; Li Z; Guo X
Adv Exp Med Biol; 2016; 948():211-221. PubMed ID: 27738987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
